Ma et al., 2019 has revealed that FGF13-AS1, downregulated in breast cancer tissue (>1-fold as compared to normal tissue), inhibits proliferation, invasive capacity, and metastasis of breast cancer cells in vitro and in vivo. Here, FGF13 is linked to breast carcinoma.